Patients with schizophrenia and other disorders who take atypical antipsychotics should be monitored for an increased risk for diabetes.
Martin Zdanowicz, PharmD
Advertisement
Articles by Martin Zdanowicz, PharmD
Advertisement
Latest Updated Articles
- Atypical Antipsychotic-Induced Type 2 Diabetes
Published: March 14th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
2
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
3
FDA Approves Reformulated Ranitidine After 5-Year Absence
4
Understanding Cyclobenzaprine Hydrochloride: An Emerging Therapy for Fibromyalgia
5
